nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—Amphetamine—CYP2A6—lung cancer	0.00591	0.284	CrCbGaD
Tolazoline—Benzyl alcohol—CYP2E1—lung cancer	0.00527	0.253	CrCbGaD
Tolazoline—Benzyl alcohol—CYP1A1—lung cancer	0.00519	0.249	CrCbGaD
Tolazoline—Phenelzine—CYP2E1—lung cancer	0.00445	0.214	CrCbGaD
Tolazoline—HRH1—Signaling Pathways—KDR—lung cancer	0.000179	0.000183	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TERT—lung cancer	0.000179	0.000183	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—MAPK3—lung cancer	0.000178	0.000181	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APOA1—lung cancer	0.000178	0.000181	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—POMC—lung cancer	0.000176	0.00018	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KDR—lung cancer	0.000176	0.00018	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MAP2K1—lung cancer	0.000176	0.000179	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CD—lung cancer	0.000175	0.000178	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—BRAF—lung cancer	0.000174	0.000178	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FGFR1—lung cancer	0.000174	0.000177	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—PIK3CA—lung cancer	0.000173	0.000177	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL6R—lung cancer	0.000172	0.000176	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CREBBP—lung cancer	0.000172	0.000176	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—KRAS—lung cancer	0.000172	0.000175	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—POMC—lung cancer	0.000171	0.000175	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HIF1A—lung cancer	0.000171	0.000175	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—KRAS—lung cancer	0.000171	0.000174	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CB—lung cancer	0.00017	0.000174	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—AKT1—lung cancer	0.00017	0.000173	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—EGFR—lung cancer	0.000169	0.000173	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTGS2—lung cancer	0.000168	0.000172	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CREBBP—lung cancer	0.000167	0.000171	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—KIT—lung cancer	0.000165	0.000169	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APC—lung cancer	0.000165	0.000169	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CG—lung cancer	0.000165	0.000169	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—NRAS—lung cancer	0.000165	0.000169	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOA1—lung cancer	0.000165	0.000168	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MAP2K1—lung cancer	0.000164	0.000168	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KDR—lung cancer	0.000163	0.000167	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGF—lung cancer	0.000163	0.000167	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CD—lung cancer	0.000163	0.000166	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KIT—lung cancer	0.000162	0.000166	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APC—lung cancer	0.000162	0.000166	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	0.000162	0.000166	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—NRAS—lung cancer	0.000162	0.000166	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—PIK3CA—lung cancer	0.000161	0.000165	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGF—lung cancer	0.00016	0.000164	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—KRAS—lung cancer	0.00016	0.000163	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CD—lung cancer	0.000158	0.000162	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—MAPK3—lung cancer	0.000158	0.000162	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PIK3CA—lung cancer	0.000158	0.000161	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—POMC—lung cancer	0.000157	0.000161	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—PIK3CA—lung cancer	0.000157	0.00016	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MDM2—lung cancer	0.000156	0.00016	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ALB—lung cancer	0.000156	0.00016	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RAF1—lung cancer	0.000156	0.000159	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—BRAF—lung cancer	0.000155	0.000159	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	0.000155	0.000159	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—POMC—lung cancer	0.000154	0.000158	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ERBB2—lung cancer	0.000154	0.000157	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL6R—lung cancer	0.000153	0.000157	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CREBBP—lung cancer	0.000153	0.000156	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TP53—lung cancer	0.000153	0.000156	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—BRAF—lung cancer	0.000152	0.000156	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MTOR—lung cancer	0.000152	0.000155	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CB—lung cancer	0.000152	0.000155	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KIT—lung cancer	0.000151	0.000154	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APC—lung cancer	0.000151	0.000154	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CG—lung cancer	0.000151	0.000154	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—NRAS—lung cancer	0.000151	0.000154	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL6R—lung cancer	0.000151	0.000154	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—EGFR—lung cancer	0.00015	0.000154	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CREBBP—lung cancer	0.00015	0.000153	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGF—lung cancer	0.000149	0.000152	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—EGFR—lung cancer	0.000148	0.000151	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTEN—lung cancer	0.000147	0.00015	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—PIK3CA—lung cancer	0.000147	0.00015	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MAP2K1—lung cancer	0.000146	0.000149	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCL8—lung cancer	0.000146	0.000149	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MDM2—lung cancer	0.000146	0.000149	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—HRAS—lung cancer	0.000146	0.000149	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RAF1—lung cancer	0.000146	0.000149	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—HRAS—lung cancer	0.000145	0.000148	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CD—lung cancer	0.000145	0.000148	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—MAPK3—lung cancer	0.000144	0.000147	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ERBB2—lung cancer	0.000144	0.000147	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—PIK3CA—lung cancer	0.000144	0.000147	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	0.000143	0.000146	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—POMC—lung cancer	0.000143	0.000146	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	0.000142	0.000146	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—KRAS—lung cancer	0.000142	0.000145	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MTOR—lung cancer	0.000142	0.000145	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CB—lung cancer	0.000142	0.000145	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—BRAF—lung cancer	0.000142	0.000145	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—AKT1—lung cancer	0.000141	0.000144	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	0.000141	0.000144	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—EP300—lung cancer	0.00014	0.000143	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CASP3—lung cancer	0.00014	0.000143	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL6R—lung cancer	0.00014	0.000143	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL2—lung cancer	0.00014	0.000143	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CREBBP—lung cancer	0.00014	0.000143	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL6—lung cancer	0.00014	0.000143	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—KRAS—lung cancer	0.00014	0.000142	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL6—lung cancer	0.000139	0.000142	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CB—lung cancer	0.000138	0.000141	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—EGFR—lung cancer	0.000137	0.00014	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTGS2—lung cancer	0.000137	0.00014	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCL8—lung cancer	0.000137	0.000139	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCND1—lung cancer	0.000136	0.000139	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—JUN—lung cancer	0.000136	0.000139	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—HRAS—lung cancer	0.000136	0.000139	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	0.000133	0.000136	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	0.000132	0.000135	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MMP9—lung cancer	0.000132	0.000135	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—AKT1—lung cancer	0.000132	0.000135	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CDKN1A—lung cancer	0.000132	0.000135	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PTEN—lung cancer	0.000131	0.000134	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	0.000131	0.000134	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CASP3—lung cancer	0.000131	0.000133	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PIK3CA—lung cancer	0.000131	0.000133	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL2—lung cancer	0.00013	0.000133	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MDM2—lung cancer	0.00013	0.000133	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL6—lung cancer	0.00013	0.000133	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RAF1—lung cancer	0.00013	0.000132	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—KRAS—lung cancer	0.00013	0.000132	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—AKT1—lung cancer	0.000129	0.000132	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ERBB2—lung cancer	0.000128	0.000131	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—AKT1—lung cancer	0.000128	0.000131	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	0.000128	0.000131	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MDM2—lung cancer	0.000128	0.00013	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RAF1—lung cancer	0.000127	0.00013	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCND1—lung cancer	0.000127	0.00013	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—JUN—lung cancer	0.000127	0.00013	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MTOR—lung cancer	0.000127	0.000129	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CB—lung cancer	0.000127	0.000129	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ERBB2—lung cancer	0.000126	0.000129	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EP300—lung cancer	0.000125	0.000128	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	0.000124	0.000127	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MTOR—lung cancer	0.000124	0.000127	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MMP9—lung cancer	0.000123	0.000126	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CDKN1A—lung cancer	0.000123	0.000126	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PTEN—lung cancer	0.000123	0.000125	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SRC—lung cancer	0.000122	0.000124	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCL8—lung cancer	0.000122	0.000124	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—HRAS—lung cancer	0.000121	0.000123	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—AKT1—lung cancer	0.00012	0.000122	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCL8—lung cancer	0.000119	0.000122	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTEN—lung cancer	0.000119	0.000122	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	0.000119	0.000122	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—VEGFA—lung cancer	0.000119	0.000121	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MDM2—lung cancer	0.000119	0.000121	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—HRAS—lung cancer	0.000119	0.000121	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RAF1—lung cancer	0.000118	0.000121	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—STAT3—lung cancer	0.000118	0.00012	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—AKT1—lung cancer	0.000118	0.00012	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NRAS—lung cancer	0.000117	0.00012	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EP300—lung cancer	0.000117	0.00012	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ERBB2—lung cancer	0.000117	0.000119	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CASP3—lung cancer	0.000116	0.000119	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL2—lung cancer	0.000116	0.000119	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL6—lung cancer	0.000116	0.000118	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	0.000115	0.000118	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MTOR—lung cancer	0.000115	0.000118	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	0.000115	0.000118	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CASP3—lung cancer	0.000114	0.000117	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL2—lung cancer	0.000114	0.000116	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SRC—lung cancer	0.000114	0.000116	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—EP300—lung cancer	0.000114	0.000116	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL6—lung cancer	0.000113	0.000116	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCND1—lung cancer	0.000113	0.000116	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—JUN—lung cancer	0.000113	0.000115	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MAPK3—lung cancer	0.000112	0.000115	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCND1—lung cancer	0.000111	0.000114	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—JUN—lung cancer	0.000111	0.000113	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCL8—lung cancer	0.000111	0.000113	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—VEGFA—lung cancer	0.000111	0.000113	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—HRAS—lung cancer	0.00011	0.000113	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MMP9—lung cancer	0.00011	0.000112	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—STAT3—lung cancer	0.00011	0.000112	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CDKN1A—lung cancer	0.00011	0.000112	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NRAS—lung cancer	0.00011	0.000112	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PTEN—lung cancer	0.000109	0.000112	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MYC—lung cancer	0.000109	0.000112	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MMP9—lung cancer	0.000108	0.00011	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	0.000108	0.00011	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PTEN—lung cancer	0.000107	0.00011	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	0.000107	0.000109	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—EGFR—lung cancer	0.000107	0.000109	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—AKT1—lung cancer	0.000107	0.000109	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CASP3—lung cancer	0.000106	0.000108	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL2—lung cancer	0.000106	0.000108	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL6—lung cancer	0.000105	0.000108	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MAPK3—lung cancer	0.000105	0.000107	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—AKT1—lung cancer	0.000105	0.000107	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EP300—lung cancer	0.000104	0.000107	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CA—lung cancer	0.000104	0.000106	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCND1—lung cancer	0.000103	0.000106	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—JUN—lung cancer	0.000103	0.000105	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EP300—lung cancer	0.000102	0.000105	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MYC—lung cancer	0.000102	0.000104	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SRC—lung cancer	0.000101	0.000104	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—KRAS—lung cancer	0.000101	0.000103	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MMP9—lung cancer	0.0001	0.000102	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	9.99e-05	0.000102	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EGFR—lung cancer	9.98e-05	0.000102	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PTEN—lung cancer	9.97e-05	0.000102	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SRC—lung cancer	9.95e-05	0.000102	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—VEGFA—lung cancer	9.88e-05	0.000101	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—STAT3—lung cancer	9.78e-05	9.99e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NRAS—lung cancer	9.76e-05	9.97e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AKT1—lung cancer	9.73e-05	9.94e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—VEGFA—lung cancer	9.69e-05	9.9e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—STAT3—lung cancer	9.6e-05	9.8e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NRAS—lung cancer	9.58e-05	9.78e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EP300—lung cancer	9.51e-05	9.71e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—KRAS—lung cancer	9.43e-05	9.63e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MAPK3—lung cancer	9.35e-05	9.54e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	9.27e-05	9.47e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SRC—lung cancer	9.25e-05	9.44e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MAPK3—lung cancer	9.17e-05	9.37e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MYC—lung cancer	9.09e-05	9.28e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—VEGFA—lung cancer	9.01e-05	9.2e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TP53—lung cancer	8.97e-05	9.16e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MYC—lung cancer	8.92e-05	9.11e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—STAT3—lung cancer	8.92e-05	9.11e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NRAS—lung cancer	8.9e-05	9.09e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EGFR—lung cancer	8.89e-05	9.08e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EGFR—lung cancer	8.72e-05	8.91e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	8.66e-05	8.85e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—HRAS—lung cancer	8.58e-05	8.76e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MAPK3—lung cancer	8.52e-05	8.7e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AKT1—lung cancer	8.46e-05	8.64e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CA—lung cancer	8.41e-05	8.59e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—KRAS—lung cancer	8.4e-05	8.58e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TP53—lung cancer	8.38e-05	8.56e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MYC—lung cancer	8.29e-05	8.46e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KRAS—lung cancer	8.24e-05	8.42e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL6—lung cancer	8.21e-05	8.39e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EGFR—lung cancer	8.11e-05	8.28e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—HRAS—lung cancer	8.01e-05	8.18e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CA—lung cancer	7.72e-05	7.88e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL6—lung cancer	7.67e-05	7.83e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KRAS—lung cancer	7.66e-05	7.82e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKT1—lung cancer	7.57e-05	7.74e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	7.57e-05	7.73e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TP53—lung cancer	7.46e-05	7.62e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TP53—lung cancer	7.32e-05	7.48e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HRAS—lung cancer	7.14e-05	7.29e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT1—lung cancer	7.08e-05	7.23e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	7.04e-05	7.18e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HRAS—lung cancer	7.01e-05	7.15e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AKT1—lung cancer	6.87e-05	7.02e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL6—lung cancer	6.83e-05	6.98e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TP53—lung cancer	6.81e-05	6.95e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL6—lung cancer	6.7e-05	6.85e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HRAS—lung cancer	6.51e-05	6.65e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT1—lung cancer	6.3e-05	6.44e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL6—lung cancer	6.23e-05	6.36e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT1—lung cancer	6.19e-05	6.32e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT1—lung cancer	5.75e-05	5.87e-05	CbGpPWpGaD
